Literature DB >> 16305728

Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy.

G Nardone1, A Rocco, S Staibano, E Mezza, G Autiero, D Compare, G De Rosa, G Budillon.   

Abstract

BACKGROUND: Histology is the gold standard for diagnosis of atrophy but is hampered by observer variation. A reliable method to overcome this issue is morphometric analysis of gastric mucosa. Serum pepsinogens and gastrin have been proposed in the diagnostic work-up of gastric atrophy although diagnostic accuracy of these tests is considered unsatisfactory. AIM: To evaluate the diagnostic accuracy of gastric serum profile in relation both to morphological and morphometric diagnosis of gastric atrophy.
METHODS: Ninety-four dyspeptic out-patients underwent upper endoscopy and evaluation of serum levels of PGI, PGII and 17-gastrin. Diagnostic accuracy of gastric serum profile was tested by receiver operating characteristic curves and by evaluation of sensitivity and specificity in relation to both histology and morphometric analyses.
RESULTS: As far as concern to histological evaluation, only PGI/PGII ratio showed an acceptable diagnostic accuracy in discrimination of gastric atrophy, while, when morphometric analysis was considered as reference, both serum PGI level and PGI/PGII ratio showed an excellent performance. However, both PGI and PGI/PGII ratio showed low sensitivity and high specificity.
CONCLUSIONS: Serological gastric profile corresponds better with the morphometric diagnosis of atrophy, even if, because of the low sensitivity, today this could only be used as screening test of chronic atrophic gastritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305728     DOI: 10.1111/j.1365-2036.2005.02734.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  21 in total

Review 1.  Secondary prevention of gastric cancer.

Authors:  Massimo Rugge
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

2.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

3.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

4.  Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer.

Authors:  Antonio Rollan; Catterina Ferreccio; Alessandra Gederlini; Carolina Serrano; Javiera Torres; Paul Harris
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

5.  H pylori infection among 1000 southern Iranian dyspeptic patients.

Authors:  Mahmood Reza Hashemi; Mohammad Rahnavardi; Bavand Bikdeli; Mohsen Dehghani Zahedani
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

6.  Risk factors in malignant transformation of gastric epithelial neoplasia categorized by the revised Vienna classification: endoscopic, pathological, and immunophenotypic features.

Authors:  Sung Hoon Jung; Woo Chul Chung; Kang-Moon Lee; Chang Nyol Paik; Ji Han Jung; Min Kyoung Lee; Yun Kyung Lee; In-Sik Chung
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

Review 7.  Screening for and surveillance of gastric cancer.

Authors:  Debora Compare; Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

8.  Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.

Authors:  Dariush Nasrollahzadeh; Karim Aghcheli; Masoud Sotoudeh; Ramin Shakeri; E Christina Persson; Farhad Islami; Farin Kamangar; Christian C Abnet; Paolo Boffetta; Lars Engstrand; Sanford M Dawsey; Reza Malekzadeh; Weimin Ye
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

Review 9.  Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.

Authors:  Ya-kai Huang; Jian-chun Yu; Wei-ming Kang; Zhi-qiang Ma; Xin Ye; Shu-bo Tian; Chao Yan
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Accuracy of GastroPanel for the diagnosis of atrophic gastritis.

Authors:  Adrian G McNicholl; Montserrat Forné; Jesus Barrio; Cristobal De la Coba; Begoña González; Robin Rivera; Maria Esteve; Fernando Fernandez-Bañares; Beatriz Madrigal; Beatriz Gras-Miralles; Angeles Perez-Aisa; Jose M Viver-Pi-Sunyer; Felipe Bory; Merce Rosinach; Carmen Loras; Carlos Esteban; Santos Santolaria; Fernando Gomollon; Julio Valle; Javier P Gisbert
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-09       Impact factor: 2.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.